This Week in Cardiology News
Curated for awag wahaw, MD

Cardiovascular Business

FDA Panel Questions Efficacy of First-Of-Its-Kind Heart Failure Device

BioPharma Dive

Blockbuster-To-Be Cardiovascular Drug Scores in Another Heart Study

JAMA Network Open

Cardiovascular Events 1 Year After Respiratory Syncytial Virus Infection in Adults

Full-Text AvailableFull-Text Available

Clinical Brief

Blood Pressure Tablets Recalled After FDA Finds Contamination

Op-Med

Too Many Doctors Choose Specialties for Their 20s, and Regret It in Their 30s. Here's Why

Journal of the American College of Cardiology

Edoxaban Dose Adjustment and Age-Associated Outcomes in Patients with Atrial Fibrillation Post-Transcatheter Aortic Valve Replacement

Full-Text AvailableFull-Text Available

Sensible Medicine

Is Anticoagulation (Actually) More Dangerous Than Low-Dose Aspirin

Opinion PieceOpinion Piece

JAMA Network Open

Empagliflozin and Dapagliflozin Outcomes in Heart Failure

Full-Text AvailableFull-Text Available

You're receiving this digest based on your specialty. Did we get it wrong? Update preferences here.